chrisvoncsefalvay/vaers-outcomes huggingface dataset:
-patients Right arm (deltoid) area became very warm & red -patient to the dr. office & had no fever, he was given a cephalosporin (he cannot remember which) -As of 10/28/19 he is starting to have some relief
Patient came into the pharmacy on 11/1/18 with a red painful/inflammed arm following vaccination with pneumovax 23 2 days prior. She said she has an appointment next week with her doctor but I was concerned she may have cellulitis so she is going to call her doctor and get in immediately. I will follow back up with her to determine outcome.
Patient developed 2 red welts on her left forearm near her wrist. They were about the size of a coin. There was no blistering but they felt warm to the touch.
Swollen lymph node left arm; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 05Aug2021 at 09:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 (Prior to the vaccination, the patient was diagnosed with COVID-19). The patient had no known allergies. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 09Aug2021 at 06:00, the patient experienced swollen lymph node left arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the event. The clinical outcome of the event swollen lymph node left arm was not resolved at the time of the report.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a pharmacist refers to a 55 year old male patient. The pharmacist reported that on an unknown date the patient was vaccinated with GARDASIL (lot # and expiration date unspecified) (dose, route and anatomical location unspecified) for prophylaxis. No adverse effect reported. Additional information has been requested.
2day p/vax 5:30pm unusual cry; pallor, taken to ER; mom suspected bowel obstruction; xray showed ileus; 7:30pm cardiac arrest: resuscitation/unconscious; sent to UCSF; 7/15 remained unstable,no possibility of surgery as result;pt died 7/15;
This was my second dosage of the Pfizer vaccine. Upon the first vaccine, I did feel symptoms of throat swelling and difficulty swallowing that subsided without intervention and quickly. For the second vaccine that I received today, I experienced dizziness in the store and began to sweat. I left because the pharmacy staff did not seem to want to be bothered. Upon driving home, within about 15 minutes of getting the vaccine, I began to have nausea to the point that I had to stop and pull over. I vomited a small amount of my breakfast. Continued to feel shaky, dizzy, faint, excessive saliva and tearing of eyes. Upon arriving in my driveway, it was hard to walk up stairs. The nausea continued for about 1.5 hours but the weakness and feelings of faintness continue still after 2 hours after the vaccine. I had some tachycardia. It's hard for my eyes to look up and my eyes hurt when I move them. I had moments of feeling like I had a parietal vice on my head. I called the pharmacy to report all of this and only spoke with a pharmacy assistant. No pharmacist called to check on me. I am an RN so I have the knowledge needed to care for myself and seek medical attention if needed, but I have sympathy for those that are not and have their report of symptoms dismissed just as I did from the vaccine provider.
Approximately 18 hours after vaccination severe joint and bone pain. Approximately 36 hours after vaccination servers headache with pulsitile tinnitus resulting in ER care
Myalgia, CoughWheeze, UrticariaPruritus, NauseaVomiting, Syncope, itching; chest congestion; fatigue body ache; n/v for the first 24 hrs of vaccinating employee Narrative:  12/29 developed itching and chest congestion that flared up my asthma.  12/30 still itching and chest congestion/ having bad fatigue, body aches, nausea and diarrhea lasted for 24 hrs.
fatigue; little pain at the injection site; muscle pain; joint pain; chills; nausea; fever; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), VACCINATION SITE PAIN (little pain at the injection site), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and CHILLS (chills) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Irritable bowel syndrome. Concomitant products included LISINOPRIL (ZESTRIL) for Blood pressure, MECLIZINE HCL for Dizziness, CHOLESTYRAMINE for Irritable bowel syndrome, HYDROCODONE BITARTRATE, PARACETAMOL (NORCO) for Pain, OMEPRAZOLE and AMLODIPINE for an unknown indication.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced FATIGUE (fatigue), VACCINATION SITE PAIN (little pain at the injection site), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (nausea) and PYREXIA (fever). At the time of the report, FATIGUE (fatigue), VACCINATION SITE PAIN (little pain at the injection site), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (nausea) and PYREXIA (fever) had resolved. Not Provided          Treatment medication included Tylenol.  Action taken with mRNA-1273 in response to the event was not applicable   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: event outcome updated(from unknown to recovered)
Mom called on 1/16/18 at 10am and states pt right thigh where the injection was given there was a 2in in diameter red swollen and hot to touch knot. Advised mom to refer to the MMRV VIS and call back with any new or continued symptoms. Mom came back into the clinic on 1/22/18 and states pt right thigh knot and redness did go away quickly that day, but then came back today and was now 1.5 in red, warm to touch and swollen. Pt had no fever in clinic and no other symptoms. Mom called back on 1/23/18 and states pt right thigh is red with a purplish center, hot and hard to touch. Mom was advised to go to urgent care and mom did not and was seen in office on 1/24/18 and was advised by Dr and Dr that this looked more like a local reaction at the vaccine site or possible fat necrosis and to call back for any streaking or induration noted. Mom understands and will do phone follow up on 1/26/18.
Pt fainted for about 1 minute, then we elevated his feet and he came back to.
Itch, hives, rash on legs and all over body. Went to walk in clinic  , also had rash on left leg, Dr said looked liked cellulitis. Trouble swallowing, could not sleep due to itching and hives  . Hard lumps with the itching rash
No adverse effects; a patient was administered PNEUMOVAX 23 - Temperature AND Time frame; This spontaneous report has been received from a registered nurse reporting on a patient of unknown age and gender. There was no information about the patient's concurrent conditions, pertinent medical history, concomitant medication, drug reactions or allergies.  On 31-MAY-2019, the patient received an unspecified dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) lot #R034248 and expiration date 07-AUG-2020 for prophylaxis (dose and route of administration were not reported) which was improperly stored. No adverse effects were reported.  It was reported that on an unspecified date, the vaccine was exposed to a temperature above 47 Fahrenheit degrees/9 Celsius degrees for 7 hours. The registered nurse reported that there was no previous temperature excursion. The call was not placed because of a Digital Data logger report.
pt recv vax & 1wk post vax a liver panel revealed elevated liver enzymes;no tx was given;
On February 5th, I received my second Moderna vaccine.  Monday the 8th, I was working from home and wasn?t feeling well.  I went to lay down and was not able to.  It was hard to breath.  I got up, went to another room where there was a recliner and sat in it trying to catch my breath.  It got harder to breathe.  I had my husband call 911. I went to the ER, had a CT scan of my chest and was found to have ?extensive PE?s?, ground glass and signs of pneumonitis.   I was admitted to the CICU for two days and was transferred for two days.  I was told by my orthopedic surgeon that there was a high unlikelihood of PE?s developing from my ankle fracture 3 months later.  I had home health care for approximately one month.
Per patient, tremors occurred in left arm (just like after the first and second Moderna dose).
DIFFICULTY IN MOVING EYES; DOUBLE VISION; BEEN INCREASING THE LAST OF 24 HOURS; NORMAL SYMPTOMS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 01-SEP-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 01-SEP-2021, the patient experienced normal symptoms. On 01-SEP-2021, the patient experienced difficulty in moving eyes. On 01-SEP-2021, the patient experienced double vision. On 01-SEP-2021, the patient experienced been increasing the last of 24 hours. The action taken with covid-19 vaccine was not applicable. The patient had not recovered from normal symptoms, difficulty in moving eyes, double vision, and been increasing the last of 24 hours. This report was non-serious.
Coughing hoarsely, lots of phlegm. Got cold, shaking like crazy, teeth shattering. Pain in chest from coughing so much. Pain in stomach ended with diarrhea. Felt like passing out. Took some TYLENOL eventually after 3 hours shaking stopped. Called pharmacist to let him know. Mouth was dry, took lots of liquids, felt very thirsty. Had fever. Next day felt fine but on Sunday 11/20 had some vaginal/urine bleeding. Spotting continues today. Making appt to follow-up with doctor. Had to ask neighbor for help on Friday to move husband since did not have much strength.
I was exposed to a positive case of COVID at work and broke out in fever for two days after my 3rd dose. I stopped having a fever on 01/02/2022 midday. I started to get cough and it was so bad I treated over the counter Dayquil and Nyquil. I tried to contact my PCP because of the cough but they refused to see me because I was not outside the days of quarantine. I went to an urgent care to make sure I hadn't developed Pneumonia. They checked me out and I was fine. At that point I didn't see my PCP until March 1, 2022 because my cough was terrible. My PCP prescribed Singular and as of a week ago today my cough is 95% and 98% this week. My PCP also did prescribe prednisone that did nothing. I did have some Post-Nasal drip that makes me nauseous.
Menstrual cycle was affected by starting period 2 weeks early and then the following cycles were irregular (41 days, 40, 84, 46, 18, 31, 25 to now 104 days and counting) now I seem to be in menopause with lots of symptoms continuing of fatigue, hot flashes, weight gain e (obvious menopause like symptoms).  The vaccine seemed to jump start menopause for me.
RA was extremely active; never been so inflammed; unable to conduct normal life functions; tired beyond what you can imagine; This spontaneous case was reported by a patient and describes the occurrence of RHEUMATOID ARTHRITIS (RA was extremely active) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Rheumatoid arthritis.    On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced RHEUMATOID ARTHRITIS (RA was extremely active) (seriousness criterion medically significant), INFLAMMATION (never been so inflammed), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (unable to conduct normal life functions) and FATIGUE (tired beyond what you can imagine). At the time of the report, RHEUMATOID ARTHRITIS (RA was extremely active), INFLAMMATION (never been so inflammed), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (unable to conduct normal life functions) and FATIGUE (tired beyond what you can imagine) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Red blood cell sedimentation rate normal: 19 (normal) 19, steadily dropped that entire year (Inconclusive) steadily dropped that entire year, 72 (High) 72 and 89 (High) 89 (3 weeks after vaccine).         No concomitant or treatment medications were reported. The patient stated, "it has been almost 2 months and there are no improvements. Even though my life has come to an abrupt halt because I am not functional, I would still take the vaccine again".  Very limited information regarding the events has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding the events has been provided at this time.  Further information has been requested.
Swollen/painful lymph node continues at time of reporting; approximately 18 hours post inoculation--soreness at lymph node in armpit of left arm began and worsened throughout day.; chills and shaky hands which subsided after about two hours.; chills and shaky hands which subsided after about two hours.; soreness at lymph node in armpit of left arm began and worsened throughout day.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 17Oct2021 12:30 (Lot number: FF8839) at the age of 40 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: INFLUENZA VACCINE INACTIVATED, administration date 05Oct2021; PRILOSEC [OMEPRAZOLE]; ALLEGRA. Vaccination history included: Bnt162b2 (DOSE 2, SINGLE, Batch/Lot No: EP6955), administration date: 24Mar2021, when the patient was 40 years old, for COVID-19 immunization; Bnt162b2 (DOSE 1, SINGLE, Batch/Lot No: EL3248), administration date: 03Mar2021, when the patient was 40 years old, for COVID-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 18Oct2021 10:00, outcome "recovering", described as "Swollen/painful lymph node continues at time of reporting"; LYMPH NODE PAIN (non-serious) with onset 18Oct2021 10:00, outcome "recovering", described as "approximately 18 hours post inoculation--soreness at lymph node in armpit of left arm began and worsened throughout day."; CHILLS (non-serious), TREMOR (non-serious) all with onset 18Oct2021 10:00, outcome "recovering" and all described as "chills and shaky hands which subsided after about two hours."; CONDITION AGGRAVATED (non-serious) with onset 18Oct2021 10:00, outcome "recovering", described as "soreness at lymph node in armpit of left arm began and worsened throughout day.". Therapeutic measures were not taken as a result of lymphadenopathy, lymph node pain, chills, tremor, condition aggravated.  Additional information: Most recent COVID-19 vaccine administration facility was Pharmacy or Drug Store. The patient had no known allergies. The patient received birth control pills within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Approximately 18 hours post inoculation--soreness at lymph node in armpit of left arm began and worsened throughout day.24hr post injection-chills and shaky hands which subsided after about two hours. Swollen/painful lymph node continued at time of reporting. The patient was not tested for COVID-19, Since the vaccination. AE did not result in physician/emergency room visit.  No follow-up attempts are possible. No further information is expected.
This non-serious spontaneous case, initially received from other non-health professional on 14-Nov-2018, concerning a female patient of unspecified age. On an unspecified date, the FLUCELVAX QIVc vaccine underwent first temperature excursion with maximum temperature (Tmax) 8.2 degrees Celsius for 4 minutes. On 22-Oct-2018, vaccine underwent second temperature excursion with Tmax 9.8 degree Celsius for 23 minutes. On an unspecified date, two temperature excursions were identified after an audit. On 29-Oct-2018, the patient was inadvertently administered FLUCELVAX QIVc (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right deltoid, batch number: 252672 and expiry date: 30-Jun-2019) which underwent temperature excursion. The patient did not experience any adverse effect after the vaccination. This case is linked to 201805262 (same reporter).
not quite 2 days later, i started having trouble breathing, and i had not had any symptoms of the asthma or the COPD because i only experience trouble breathing after a case of the flu or a severe cold, which always leads to congestion, and often pneumonia.   There was constant coughing and gasping for air, a tightness in my chest.  I went online to see if there were any other people who had experienced this, and the literature was saying the problems with breathing usually start within a few hours, but mine took longer and I know it was related to the vaccine.  I was given  an ADVAIR inhaler which did nothing to alleviate the symptoms, so then had 3 weeks of prednisone, to the point i did not want to go for the second dose, but my doctor talked me into it as I have so many pre-existing conditions.  I had no problem at all with the second dose and am now off the prednisone and the advair
This case was reported by a pharmacist and described the occurrence of generalized itching (no specific area recorded) in a male subject of unspecified age who was vaccinated with ENGERIX B (GlaxoSmithKline). On 15 January 2013 the subject received 1st dose of ENGERIX B (intramuscular, left deltoid). On 15 January 2013, within hours of vaccination with ENGERIX B, the subject experienced generalized itching (no specific area recorded). At the time of reporting the event was resolved. Per the reporter, the subject stated the generalized itching "went away after a few days." The subject consulted his physician and did not require intervention at the physician's office. The vaccination course with ENGERIX B was discontinued. The physician "decided that the patient is not going to receive the other dose series" of ENGERIX B. The pharmacist reported two cases with ENGERIX B. See case A1013166A for details on the other case.
tingling, numbness in vaccinated arm spreading to top of head, face, entire torso lt side;heart racing, nauseated, lightheaded;had to pull over roadside call 911;pulse & BP very high;resolved p/1hr;
This spontaneous report as received from a Practice Manager via company representative referring a patient of unknown age who on 26-FEB-2014 the patient was vaccinated with PNEUMOVAX 23 lot # J014401, exp date 26-NOV-2014 (dose and route not provided). On an unknown date the patient experienced a reaction. The outcome of reaction was unknown. Additional information has been requested.
Pt has been short of breath for 2 days.  She has a history of CAD, PE and is not on chronic anticoagulation therapy.  She had recent travel and developed a cough, congestion, and a runny nose.  She has tested positive for COVID and has bilateral infiltrates on her xray.
a patient received his second dose of PNEUMOVAX 23 on 12/10/2019 and "a couple hours after the injection" started experiencing "pain, swelling and redness at the injection site in the right triceps area down to the patients right elbow."; a patient received his second dose of PNEUMOVAX 23 on 12/10/2019 and "a couple hours after the injection" started experiencing "pain, swelling and redness at the injection site in the right triceps area down to the patients right elbow."; a patient received his second dose of PNEUMOVAX 23 on 12/10/2019 and "a couple hours after the injection" started experiencing "pain, swelling and redness at the injection site in the right triceps area down to the patients right elbow."; This spontaneous report was received from a nurse referring to a 78 years old male patient. Concomitant therapies included metformin, rosuvastatin and metoprolol.  Concurrent conditions included diabetes and hypertension. No drug reaction/allergy.  On 26-NOV-2014, the patient was vaccinated with the first dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (strength, vaccine dosage detail, route of administration, lot# and expiration date were not reported) for prophylaxis. On 10-DEC-2019, the patient was vaccinated with the second dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot# S029916, expiration date 12-JUN-2021; strength and vaccine dosage detail were not reported) intramuscularly in the right tricep for prophylaxis.  On the same day, a couple hours after the injection the patient started experiencing pain, swelling and redness at the injection site in the right triceps area down to the patient's right elbow. The patient came back to the office to seek medical attention on 11-DEC-2019. No treatment, lab diagnostics or intervention was given for the events. No product quality complaint (PQC) was involved in this case. The outcome of the events was not recovered. The causality between the events and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not provided.
This spontaneous report was received from a medical assistant refers to a 12 month old female patient. On 14-OCT-2014, the patient was vaccinated with a dose of VAQTA (lot # K008219, expiry date: not provided) dose 1, 0.5 ml, intramuscular in the left leg (reported as left vastus lateralis (VL), that had been improperly stored. Number of previous doses reported as 0. There had been no reported adverse events and no need for revaccination from the time of administration. The staff was still gathering information regarding the reported adverse event incorrect product storage. No adverse reaction was reported. This is one of several reports received from the same source (MARRS # 1411USA008692, MARRS # 1501USA004615 and MARRS # 1501USA004616). Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a 20 year old patient. When approximately 5 years old, in approximately 1998 the patient was vaccinated with a first dose of VARIVAX (Merck) (dose, route and lot # unknown) and never received the second dose. No adverse symptoms reported. Pharmacist stated the patient will now be entering radiology school and the school is requiring that 2 doses of VARIVAX (Merck) be administered. Pharmacist mentioned no titers had been drawn for this patient. Additional information has been requested.